4//SEC Filing
Craig Adam R 4
Accession 0000899243-23-008753
CIK 0000891293other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 5:52 PM ET
Size
5.5 KB
Accession
0000899243-23-008753
Insider Transaction Report
Form 4
Craig Adam R
DirectorSee Remarks
Transactions
- Award
Stock Option (right to buy)
2023-03-14+900,000→ 900,000 totalExercise: $4.55Exp: 2033-03-14→ Common Stock (900,000 underlying)
Footnotes (1)
- [F1]The stock option will vest in six equal semi-annual installments over a three-year period, subject to continued employment with the Company through the applicable vesting dates.
Documents
Issuer
CTI BIOPHARMA CORP
CIK 0000891293
Entity typeother
Related Parties
1- filerCIK 0001339498
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 5:52 PM ET
- Size
- 5.5 KB